The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Human NKT Cells Mediate Antitumor Cytotoxicity Directly by Recognizing Target Cell CD1d with Bound Ligand or Indirectly by Producing IL-2 to Activate NK Cells
Abstract
α-Galactosylceramide (αGalCer) stimulates NKT cells and has antitumor activity in mice. Murine NKT cells may directly kill tumor cells and induce NK cell cytotoxicity, but the mechanisms are not well defined. Newly developed human CD1d/αGalCer tetrameric complexes were used to obtain highly purified human αGalCer-reactive NKT cell lines (>99%), and the mechanisms of NKT cell cytotoxicity and activation of NK cells were investigated. Human NKT cells were cytotoxic against CD1d− neuroblastoma cells only when they were rendered CD1d+ by transfection and pulsed with αGalCer. Four other CD1d− tumor cell lines of diverse origin were resistant to NKT cells, whereas Jurkat and U937 leukemia cell lines, which are constitutively CD1d+, were killed. Killing of the latter was greatly augmented in the presence of αGalCer. Upon human CD1d/αGalCer recognition, NKT cells induced potent cytotoxicity of NK cells against CD1d− neuroblastoma cell lines that were not killed directly by NKT cells. NK cell activation depended upon NKT cell production of IL-2, and was enhanced by secretion of IFN-γ. These data demonstrate that cytotoxicity of human NKT cells can be CD1d and ligand dependent, and that TCR-stimulated NKT cells produce IL-2 that is required to induce NK cell cytotoxicity. Thus, NKT cells can mediate potent antitumor activity both directly by targeting CD1d and indirectly by activating NK cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral Vector
Naldini, L., Blömer, U., Gallay, P., Ory, D., Mulligan, R., Gage, F. H., Verma, I. M., & Trono, D. (1996) · Science · doi:10.1126/science.272.5259.263 · Cited by 4,903
Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo
Zufferey, R., Nagy, D., Mandel, R. J., Naldini, L., & Trono, D. (1997) · Nature Biotechnology · doi:10.1038/nbt0997-871 · Cited by 1,977
MOUSE CD1-SPECIFIC NK1 T CELLS: Development, Specificity, and Function
Bendelac, A., Rivera, M. N., Park, S.-H., & Roark, J. H. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.535 · Cited by 1,326
Requirement for V α 14 NKT Cells in IL-12-Mediated Rejection of Tumors
Cui, J., Shin, T., Kawano, T., Sato, H., Kondo, E., Toura, I., Kaneko, Y., Koseki, H., Kanno, M., & Taniguchi, M. (1997) · Science · doi:10.1126/science.278.5343.1623 · Cited by 1,237
Tracking the Response of Natural Killer T Cells to a Glycolipid Antigen Using Cd1d Tetramers
Matsuda, J. L., Naidenko, O. V., Gapin, L., Nakayama, T., Taniguchi, M., Wang, C.-R., Koezuka, Y., & Kronenberg, M. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.5.741 · Cited by 887
Self-citationNKT cells: facts, functions and fallacies
Godfrey, D. I., Hammond, K. J. L., Poulton, L. D., Smyth, M. J., & Baxter, A. G. (2000) · Immunology Today · doi:10.1016/s0167-5699(00)01735-7 · Cited by 858
Carnaud, C., Lee, D., Donnars, O., Park, S.-H., Beavis, A., Koezuka, Y., & Bendelac, A. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.9.4647 · Cited by 854
Differential Tumor Surveillance by Natural Killer (Nk) and Nkt Cells
Smyth, M. J., Thia, K. Y. T., Street, S. E. A., Cretney, E., Trapani, J. A., Taniguchi, M., Kawano, T., Pelikan, S. B., Crowe, N. Y., & Godfrey, D. I. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.4.661 · Cited by 829
Gunning, P., Leavitt, J., Muscat, G., Ng, S. Y., & Kedes, L. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.14.4831 · Cited by 739
THE CD1 SYSTEM: Antigen-Presenting Molecules for T Cell Recognition of Lipids and Glycolipids
Porcelli, S. A., & Modlin, R. L. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.297 · Cited by 704
NKT cell–mediated repression of tumor immunosurveillance by IL-13 and the IL-4R–STAT6 pathway
Terabe, M., Matsui, S., Noben-Trauth, N., Chen, H., Watson, C., Donaldson, D. D., Carbone, D. P., Paul, W. E., & Berzofsky, J. A. (2000) · Nature Immunology · doi:10.1038/82771 · Cited by 699
Brossay, L., Chioda, M., Burdin, N., Koezuka, Y., Casorati, G., Dellabona, P., & Kronenberg, M. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.8.1521 · Cited by 642
Self-citationKitamura, H., Iwakabe, K., Yahata, T., Nishimura, S.-I., Ohta, A., Ohmi, Y., Sato, M., Takeda, K., Okumura, K., Van Kaer, L., et al. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.7.1121 · Cited by 626
Structure-Activity Relationship of .alpha.-Galactosylceramides against B16-Bearing Mice
Morita, M., Motoki, K., Akimoto, K., Natori, T., Sakai, T., Sawa, E., Yamaji, K., Koezuka, Y., Kobayashi, E., & Fukushima, H. (1995) · Journal of Medicinal Chemistry · doi:10.1021/jm00012a018 · Cited by 599
Requirements for CD1d Recognition by Human Invariant Vα24+ CD4−CD8− T Cells
Exley, M., Garcia, J., Balk, S. P., & Porcelli, S. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.1.109 · Cited by 531
Lysis of fresh and cultured autologous tumor by human lymphocytes cultured in T-cell growth factor.
Lotze, M. T., Grimm, E. A., Mazumder, A., Strausser, J. L., & Rosenberg, S. A. (1981) · PubMed · Cited by 523
Kawano, T., Cui, J., Koezuka, Y., Toura, I., Kaneko, Y., Sato, H., Kondo, E., Harada, M., Koseki, H., Nakayama, T., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.10.5690 · Cited by 476
CD1d-restricted Recognition of Synthetic Glycolipid Antigens by Human Natural Killer T Cells
Spada, F. M., Koezuka, Y., & Porcelli, S. A. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.8.1529 · Cited by 438
Lanier, L. L., Chang, C., & Phillips, J. H. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.153.6.2417 · Cited by 420
Simultaneous quantitation of 15 cytokines using a multiplexed flow cytometric assay
Carson, R. T., & Vignali, D. A. A. (1999) · Journal of Immunological Methods · doi:10.1016/s0022-1759(99)00069-1 · Cited by 402
Burdin, N., Brossay, L., Koezuka, Y., Smiley, S. T., Grusby, M. J., Gui, M., Taniguchi, M., Hayakawa, K., & Kronenberg, M. (1998) · PubMed · Cited by 381
Self-citationBurdin, N., Brossay, L., Koezuka, Y., Smiley, S. T., Grusby, M. J., Gui, M., Taniguchi, M., Hayakawa, K., & Kronenberg, M. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.7.3271 · Cited by 334
Self-citationSelective induction of NK cell proliferation and cytotoxicity by activated NKT cells
Eberl, G., & MacDonald, H. R. (2000) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(200004)30:4<985::aid-immu985>3.0.co;2-e · Cited by 326
Brodsky, F. M., Bodmer, W. F., & Parham, P. (1979) · European Journal of Immunology · doi:10.1002/eji.1830090709 · Cited by 304
Rosenstein, M., Yron, I., Kaufmann, Y., & Rosenberg, S. A. (1984) · PubMed · Cited by 297
Expression of a nonpolymorphic MHC class I-like molecule, CD1D, by human intestinal epithelial cells
Blumberg, R. S., Terhorst, C., Bleicher, P., McDermott, F. V., Allan, C. H., Landau, S. B., Trier, J. S., & Balk, S. P. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.8.2518 · Cited by 264
Toura, I., Kawano, T., Akutsu, Y., et al. (1999) · PubMed · Cited by 260
Antitumor cytotoxicity mediated by ligand-activated human V alpha24 NKT cells.
Kawano, T., Nakayama, T., Kamada, N., Kaneko, Y., Harada, M., Ogura, N., Akutsu, Y., Motohashi, S., Iizasa, T., Endo, H., et al. (1999) · PubMed · Cited by 258
Sonoda, K.-H., Faunce, D. E., Taniguchi, M., Exley, M., Balk, S., & Stein-Streilein, J. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.1.42 · Cited by 240
Toura, I., Kawano, T., Akutsu, Y., Nakayama, T., Ochiai, T., & Taniguchi, M. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.5.2387 · Cited by 235
Seeger, R. C., Rayner, S. A., Banerjee, A., Chung, H. S., Laug, W. E., Neustein, H. B., & Benedict, W. F. (1977) · PubMed · Cited by 231
Self-citationBonish, B., Jullien, D., Dutronc, Y., Huang, B. B., Modlin, R., Spada, F. M., Porcelli, S. A., & Nickoloff, B. J. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.7.4076 · Cited by 220
Chen, R., Lowe, L., Wilson, J. D., Crowther, E., Tzeggai, K., Bishop, J. E., & Varro, R. (1999) · Clinical Chemistry · doi:10.1093/clinchem/45.9.1693 · Cited by 215
Exley, M., Porcelli, S., Furman, M., Garcia, J., & Balk, S. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.5.867 · Cited by 194
Keshelava, N., Seeger, R. C., Groshen, S. G., & Reynolds, C. P. (1998) · PubMed · Cited by 187
Self-citationOchoa, A. C., Gromo, G., Alter, B. J., Sondel, P. M., & Bach, F. H. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.138.8.2728 · Cited by 176
Nakagawa, R., Motoki, K., Ueno, H., et al. (1998) · PubMed · Cited by 165
Perforin-dependent NK cell cytotoxicity is sufficient for anti-metastatic effect of IL-12
Kodama, T., Takeda, K., Shimozato, O., Hayakawa, Y., Atsuta, M., Kobayashi, K., Ito, M., Yagita∥, H., & Okumura, K. (1999) · European Journal of Immunology · Cited by 155
Nieda, M. (2001) · Blood · doi:10.1182/blood.v97.7.2067 · Cited by 155
Sakoda, T., Kasahara, N., Hamamori, Y., & Kedes, L. (1999) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1999.1035 · Cited by 143
Structural requirements for galactosylceramide recognition by CD1-restricted NK T cells.
Brossay, L., Naidenko, O. V., Burdin, N., Matsuda, J. L., Sakai, T., & Kronenberg, M. (1998) · PubMed · Cited by 141
Self-citationTakahashi, T., Nieda, M., Koezuka, Y., Nicol, A. J., Porcelli, S. A., Ishikawa, Y., Tadokoro, K., Hirai, H., & Juji, T. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.9.4458 · Cited by 139
Brossay, L., Naidenko, O. V., Burdin, N., Matsuda, J. L., Sakai, T., & Kronenberg, M. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.10.5124 · Cited by 131
Self-citationNicol, A. J., Nieda, M., Koezuka, Y., Porcelli, S. A., Suzuki, K., Tadokoro, K., Durrant, S., & Juji, T. (2000) · Immunology · doi:10.1046/j.1365-2567.2000.00952.x · Cited by 117
Main, E. K., Lampson, L. A., Hart, M. K., Kornbluth, J., & Wilson, D. (1985) · The Journal of Immunology · doi:10.4049/jimmunol.135.1.242 · Cited by 100
Nakagawa, R., Serizawa, I., Motoki, K., Sato, M., Ueno, H., Iijima, R., Nakamura, H. K., Shimosaka, A., & Koezuka, Y. (2001) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/096504001108747521 · Cited by 82
Yang, O. O., Racke, F. K., Nguyen, P., et al. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.7.3756 · Cited by 68
Sayers, T. J., Mason, A. T., & Ortaldo, J. R. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.136.6.2176 · Cited by 57
Ishihara, S., Nieda, M., Kitayama, J., Osada, T., Yabe, T., Kikuchi, A., Koezuka, Y., Porcelli, S. A., Tadokoro, K., Nagawa, H., et al. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.3.1659 · Cited by 51
Brossay, L., Burdin, N., Tangri, S., & Kronenbers, M. (1998) · Immunological Reviews · doi:10.1111/j.1600-065x.1998.tb01193.x · Cited by 49
Nakagawa, R., Motoki, K., Nakamura, H. K., Ueno, H., Iijima, R., Yamauchi, A., Tsuyuki, S., Inamoto, T., & Koezuka, Y. (1998) · PubMed · Cited by 48
The identification of the β2‐microglobulin binding antigen encoded by the human CDID gene
Bilsland, C. A., & Milstein, C. (1991) · European Journal of Immunology · doi:10.1002/eji.1830210112 · Cited by 44
Proffitt, R. T., Tran, J. V., & Reynolds, C. P. (1996) · Cytometry · Cited by 40
Andrews, K. J., Ribas, A., Butterfield, L. H., Vollmer, C. M., Eilber, F. C., Dissette, V. B., Nelson, S. D., Shintaku, P. I., Mekhoubad, S., Nakayama, T., et al. (2000) · PubMed · Cited by 28
Activation-induced expression of CD1d antigen on mature T cells
Salamone, M. D. C., Rabinovich, G. A., Mendiguren, A. K., Salamone, G. V., & Fainboim, L. (2001) · Journal of Leukocyte Biology · doi:10.1189/jlb.69.2.207 · Cited by 20
Makni, H., Malter, J. S., Reed, J. C., Nobuhiko, S., Lang, G., Kioussis, D., Trinchieri, G., & Kamoun, M. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.146.8.2522 · Cited by 19
Multiple Color Immunofluorescence for Cytokine Detection at the Single Cell Level
Loza, M. J., Faust, J. S., & PERUSSIA, B. (2003) · Humana Press eBooks · doi:10.1385/1-59259-044-6:193 · Cited by 5
Self-citation
Cited by
CD1: Antigen Presentation and T Cell Function
Brigl, M., & Brenner, M. B. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104608 · Cited by 1,035
TOWARD AN UNDERSTANDING OF NKT CELL BIOLOGY: Progress and Paradoxes
Kronenberg, M. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115742 · Cited by 1,029
Self-citationDhodapkar, M. V., Geller, M. D., Chang, D. H., Shimizu, K., Fujii, S.-I., Dhodapkar, K. M., & Krasovsky, J. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021650 · Cited by 425
Presumed guilty: natural killer T cell defects and human disease
Berzins, S. P., Smyth, M. J., & Baxter, A. G. (2011) · Nature Reviews Immunology · doi:10.1038/nri2904 · Cited by 365
Vα24-invariant NKT cells mediate antitumor activity via killing of tumor-associated macrophages
Song, L., Asgharzadeh, S., Salo, J., Engell, K., Wu, H.-W., Sposto, R., Ara, T., Silverman, A. M., DeClerck, Y. A., Seeger, R. C., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37869 · Cited by 342
Self-citation
Metadata
- Authors
- Metelitsa, L. S., Naidenko, O. V., Kant, A., Wu, H.-W., Loza, M. J., Perussia, B., Kronenberg, M., & Seeger, R. C.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2001-09
- Volume
- 167
- Issue
- 6
- Pages
- 3114-3122
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W2114565147
- Cited by
- 355
- References
- 57
- FWCI
- 5.72
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.